Home Featured Page 207

Featured

Latest

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry

Ibogaine and Cardiac Arrhythmia: The Heart of the Matter

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening...

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals...

Wesana Health Reports Q3 2021 Financial Results

Awakn Life Sciences Strengthens Executive Leadership Team

PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your...

MindMed and Liechti Lab publish first human data on the interacting...

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic...

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

1...206207208...308 Page 207 of 308

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human Psyche

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples Therapy

Taking the Helm at Helus: A Brief Q&A With New CEO Michael Cola

The Psychedelic Practitioner Issue 3: Dosing

Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry

Ibogaine and Cardiac Arrhythmia: The Heart of the Matter

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening...

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals...

Wesana Health Reports Q3 2021 Financial Results

Awakn Life Sciences Strengthens Executive Leadership Team

PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your...

MindMed and Liechti Lab publish first human data on the interacting...

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic...

MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation

EDITOR PICKS

Ketamine Assisted Psychotherapy for Couples

Psychedelics, Depth, and the Human Psyche: Psychedelics, Depth, and the Human...

Dr. Chandra Khalifian and Dr. Kayla Knopp: Enamory, Psychedelics, and Couples...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY